Worldwide has the Agility and Global Presence Your Behcet’s Clinical Trial Needs
Behçet’s disease, or Behçet’s syndrome, is a rare condition characterized by inflammation of blood vessels throughout the body. Because symptoms vary a great deal and may appear to be unrelated, the condition can often be misdiagnosed. The cause of Behçet’s disease is not definitively identified, and current treatments aim to control the symptoms and prevent serious complications. Because the condition is rare and difficult to diagnose, researchers face challenges related to patient recruitment and regulatory uncertainties. And because Behçet’s is statistically more prevalent in regions of Africa and the Middle East, access to these remote patient populations is crucial to achieving sufficient enrollment numbers.
A midsize CRO with a global reach, Worldwide Clinical Trials has just the right mix of agility and resources to take on the challenge of complex conditions like Behçet’s disease. Our expertise in designing innovative protocols and identifying alternative study end points means your study will be adaptive and flexible. And because we have investigator sites in 60+ countries worldwide, we have access to remote patient populations. But more than that, we have an intimate understanding of regional variations in regulatory concerns and standards of care, which equips us to select those locations most likely to render the precise data required.